PK ! 1T T xl/worksheets/sheet1.xml
0
12
13
14
15
PK ! 4\ \ xl/worksheets/sheet2.xml
6
7
89
1011
1213
1415
1617
1819
PK ! F" " xl/worksheets/sheet3.xml
20
21
2223
8497633493105
24323062301543
25174571191562
269866590726
275279848182
287643582
294342802
30-232631
32731363
3320031
342330545907
35
36-33335-33885
37-20132088
382122794
39-33226-31003
40-992114904
41-3461359
42-646014545
434742-7839
44-17186706
45-43831
46-21566706
47
48-0.010.05
49-0.010.04
50
48149892148013
49149892151220
PK ! yX) ) xl/worksheets/sheet4.xml
51
5253
54
55
56210477247790
5760688949
58538309662583
59512241489389
60121408110218
6111751179
6213896781520108
63500911514158
64602893593017
6512098181166922
663767539899
671984620471
686420464475
696394320614
7038889683939664
71
72
73539734583345
743052330614
7599019686
7626922636
7732333101
781596047861
79602043677243
8026726612680053
813844338038
823037832894
831809318783
846028660251
85103719619
863286638903
8728630982878541
881642016907
89407407366973
9038889683939664
PK ! fb2, 2, xl/worksheets/sheet5.xml
91
21
2223
92
42-646014545
93
945781555549
953140-1970
9621952183
9780655330
98357816021
3320031
9911551431
100
58124268108385
59-25549-20283
101-4423602
614301
102-48777-37226
10351323260
104120343148128
105
106-10793-11776
107-1888-917
108-8471431
109-97395-12693
110
111-9796-23630
112111676
113-3001-2102
114-316431
115-172231
116-4399831
11731-93
11831-1000
119-61570-26149
120-1572-593
121-40194108693
122256739347121
123216545455814
124210477452097
12560683717
123216545455814
PK ! QcM{ { xl/worksheets/sheet6.xml
126
21
2223
42-646014545
127
363333533885
128-3461359
945781555549
12981229104338
127
13080655330
13155895792
132731363
13331114
134-232631
13531323
1362013-2088
137500031
3320031
138-641999
13999860115171
PK ! ꄔr xl/worksheets/sheet7.xml
140
21
2223
42-646014545
127
14119821972
142-3461359
1433915239514
13080655330
14455895792
132731363
13331114
134-232631
13531323
137500031
3320031
138-500999
145-10185-15053
146-2199-1796
1473558852462
148304630303337
1490.120.17
PK ! tnN# N# xl/worksheets/sheet8.xml
150
151152
153154155153154155
8317747156317747312508156312508
157199030-15091183939185298-12019173279
251187171509113380812721012019139229
158159160161162
16327593-62502134318762-82417938
16443221-11594206236117-100235115
1651674-167431313131
28772317723582313582
32206-2063180-8031
34452512438069631686691392582594
PK ! 8>q xl/worksheets/sheet9.xml
150
151152
153154155153154155
885086156850869593115695931
16643853-266531720048198-2749320705
25412332665367886477332749375226
158167168169170
17124400-6132378719881-59119290
1729577-326925112065-18011885
173200-20031313131
174-831-8313131
3470642779234856157872826444051
PK ! xl/worksheets/sheet10.xml
150
151152
153154155153154155
894800156948008466615684666
24801793180179680473168047
25146213114621166193116619
158175175176176
17113410-4526888413704-61847520
177313131931-93131
178121145265737198471159099
PK ! 9 @ @ xl/worksheets/sheet11.xml
179
180181
182183184185182186
42-20459-609232176145452017068578
127
3633957344003408333885136325145998
12841404049264835911196-104358
9461183601865648755549233406235387
1297882192543125394104338401097345605
127
13077427708763253302841220750
18760272220596457922000323384
3231425313637882398
1331644871142616574
1886000190003131250005610
135223536887413232410543629
136170292244-2088355-16350
1893131313131-123
190456624967847108862579522771
33-100300313120031
191-281881863131536831
1383592128280799966801926
192126369134921150716126057538064456174
193-4566-2496-7847-10886-25795-22771
194121803132425142869115171512269433403
PK ! <.N .N xl/worksheets/sheet12.xml
179
180181
182183184185182186
42-20459-609232176145452017068578
127
141212321832077197283557900
19541404049264835911196-104358
14341543416514136139514164069163842
13077427708763253302841220750
18760272220596457922000323384
3231425313637882398
1331644871142616574
1886000190003131250005610
135223536887413232410543629
1963131313131-16350
1893131313131-123
190456624967847108862579522771
33-100300313120031
191-281881863131536831
1383592128280799966801926
197-19313-17346-21779-17339-75777-54271
198-1191-1541-2054-1796-6582-1240
19954221652537750761062258043191020
193-4566-2496-7847-10886-25795-22771
20011205251647228655784640
20150775632827130752462237826172889
202304429303861304103303337303937301030
2030.180.210.250.20.850.63
2040.170.210.230.170.780.57
PK ! ൩ xl/workbook.xml
PK ! Gg ( ( xl/sharedStrings.xml
N/A☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))Maintaining Full Year 2022 Financial OutlookFull Year 2022 Financial GuidanceNet revenue$2.15 billion - $2.25 billionAdjusted EBITDA (1)$540 million - $560 millionAdjusted diluted EPS (2)$0.80 - $0.85Operating cash flow (3)$225 million - $250 millionCapital expenditures$75 million - $85 millionWeighted average diluted shares outstanding (4)Approximately 307 millionConsolidated Statements of OperationsThree Months Ended March 31,20222021Cost of goods soldGross profitSelling, general and administrativeResearch and developmentIntellectual property legal development expensesAcquisition, transaction-related and integration expensesCredit related to legal matters, net—Restructuring and other chargesChange in fair value of contingent considerationOperating incomeOther (expense) income:Interest expense, netForeign exchange (loss) gain, netOther income, netTotal other expense, net(Loss) income before income taxes(Benefit from) provision for income taxesNet (loss) incomeLess: Net loss (income) attributable to non-controlling interestsNet (loss) income attributable to Amneal Pharmaceuticals, Inc. before accretion of redeemable non-controlling interestAccretion of redeemable non-controlling interestNet (loss) income attributable to Amneal Pharmaceuticals, Inc.Net (loss) income per share attributable to Amneal Pharmaceuticals, Inc.'s class A common stockholders:BasicDilutedWeighted-average common shares outstanding:Condensed Consolidated Balance SheetsMarch 31, 2022December 31, 2021AssetsCurrent assets:Cash and cash equivalentsRestricted cashTrade accounts receivable, netInventoriesPrepaid expenses and other current assetsRelated party receivablesTotal current assetsProperty, plant and equipment, netGoodwillIntangible assets, netOperating lease right-of-use assetsOperating lease right-of-use assets - related partyFinancing lease right-of-use assetsOther assetsTotal assetsLiabilities and Stockholders' EquityCurrent liabilities:Accounts payable and accrued expensesCurrent portion of long-term debt, netCurrent portion of operating lease liabilitiesCurrent portion of operating and financing lease liabilities - related partyCurrent portion of financing lease liabilitiesRelated party payables - short termTotal current liabilitiesLong-term debt, netNote payable - related partyOperating lease liabilitiesOperating lease liabilities - related partyFinancing lease liabilitiesRelated party payables - long termOther long-term liabilitiesTotal long-term liabilitiesRedeemable non-controlling interestsTotal stockholders' equityTotal liabilities and stockholders' equityConsolidated Statements of Cash FlowsCash flows from operating activities:Adjustments to reconcile net (loss) income to net cash provided by operating activities:Depreciation and amortizationUnrealized foreign currency loss (gain)Amortization of debt issuance costs and discountStock-based compensationInventory provisionOther operating charges and credits, netChanges in assets and liabilities:Prepaid expenses, other current assets and other assetsAccounts payable, accrued expenses and other liabilitiesRelated party payablesNet cash provided by operating activitiesCash flows from investing activities:Purchases of property, plant and equipmentDeposits for future acquisition of property, plant, and equipmentAcquisition of businessNet cash used in investing activitiesCash flows from financing activities:Payments of principal on debt, financing leases and otherProceeds from exercise of stock optionsEmployee payroll tax withholding on restricted stock unit vestingTax distributions to non-controlling interestsAcquisition of redeemable non-controlling interestPayments of deferred consideration for acquisitions - related partyPayments of principal on financing lease - related partyRepayment of related party noteNet cash used in financing activitiesEffect of foreign exchange rate on cashNet (decrease) increase in cash, cash equivalents, and restricted cashCash, cash equivalents, and restricted cash - beginning of periodCash, cash equivalents, and restricted cash - end of periodCash and cash equivalents - end of periodRestricted cash - end of periodReconciliation of Net (Loss) Income to EBITDA and Adjusted EBITDAAdjusted to add (deduct):Income tax expense (benefit)EBITDA (Non-GAAP)Stock-based compensation expenseAcquisition, site closure, and idle facility expenses (2)Restructuring and other charges (3)Inventory related chargesCredit related to legal matters, net (4)Asset impairment chargesForeign exchange loss (gain)Regulatory approval milestoneOtherAdjusted EBITDA (Non-GAAP)Reconciliation of Net (Loss) Income to Adjusted Net Income and Calculation of Adjusted Diluted Earnings Per ShareNon-cash interestGAAP Income tax (benefit) expenseAmortizationAcquisition, site closure expenses, and idle facility expenses (2)Income tax (5)Net income attributable to non-controlling interests not associated with our class B common stockAdjusted net income (Non-GAAP)Weighted average diluted shares outstanding (Non-GAAP) (6)Adjusted diluted earnings per share (Non-GAAP)(Unaudited; In thousands)Three Months Ended March 31, 2022Three Months Ended March 31, 2021As ReportedAdjustmentsNon-GAAP$—Cost of goods sold (2)Gross margin %37.4%42.1%40.7%44.6%Selling, general and administrative (3)Research and development (4)Charges related to legal matters, net (5)Cost of goods sold (1)48.5%79.8%49.8%78.4%Selling, general and administrative (2)Research and development (3)Change in fair value of contingent consideration (4)Intellectual property legal development credit15.4%19.6%Acquisition, transaction-related and integration expenses (3)Operating income (loss)(Unaudited; In thousands, except per share amounts)Three months endedYear endedDec. 31, 2021Sept. 30, 2021June 30, 2021March 31, 2021Dec. 31, 2020Acquisition, site closure, and idle facility expensesCharges related to legal matters, netGain on sale of international businesses, netResearch and development milestonesProperty losses and associated expenses, netAdjusted EBITDA (Non-GAAP), as previously reportedResearch and development milestones (1)Adjusted EBITDA (Non-GAAP), as revisedGAAP Income tax expense (benefit)Foreign exchange gainIncome taxNet income attributable to non-controlling interests not associated with our Class B common stockAdjusted net income (Non-GAAP), as previously reportedIncome tax impact of revisionAdjusted net income (Non-GAAP), as revisedWeighted average diluted shares outstanding (Non-GAAP) (2)Adjusted diluted EPS (Non-GAAP), as previously reportedAdjusted diluted EPS (Non-GAAP), as revisedPK ! m docProps/app.xml
Microsoft Excel0falseWorksheets12namaintaining full year 2022operationscondensed consolidated balcash flowsreconciliation of net lossreconciliation of net loss-1unaudited in thousandsunaudited in thousands-1unaudited in thousands-2unaudited in thousands excunaudited in thousands exc-1falsefalsefalse12.0000PK ! o\P P docProps/core.xml
2022-05-04T10:20:55Z2022-05-04T10:20:55ZPK ! ;j
j
[Content_Types].xml
PK ! pܘBS S
xl/styles.xml
PK ! FTR R xl/theme/theme1.xml
PK ! IK K _rels/.rels
PK ! E{ xl/_rels/workbook.xml.rels
PK ! 1T T xl/worksheets/sheet1.xmlPK ! 4\ \ xl/worksheets/sheet2.xmlPK ! F" " xl/worksheets/sheet3.xmlPK ! yX) ) 8/ xl/worksheets/sheet4.xmlPK ! fb2, 2, JY xl/worksheets/sheet5.xmlPK ! QcM{ { xl/worksheets/sheet6.xmlPK ! ꄔr c xl/worksheets/sheet7.xmlPK ! tnN# N# xl/worksheets/sheet8.xmlPK ! 8>q xl/worksheets/sheet9.xmlPK ! O xl/worksheets/sheet10.xmlPK ! 9 @ @ 6 xl/worksheets/sheet11.xmlPK ! <.N .N mQ xl/worksheets/sheet12.xmlPK ! ൩ ҟ xl/workbook.xmlPK ! Gg ( ( ٤ xl/sharedStrings.xmlPK ! m docProps/app.xmlPK ! o\P P docProps/core.xmlPK ! ;j
j
s [Content_Types].xmlPK ! pܘBS S
xl/styles.xmlPK ! FTR R xl/theme/theme1.xmlPK ! IK K _rels/.relsPK ! E{ xl/_rels/workbook.xml.relsPK